NCT05043168View on ClinicalTrials.gov

Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

September 18, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

May 17, 2022

Conditions
Covid19Vaccination Reaction
Trial Locations (1)

35392

University Clinic Giessen and Marburg - Campus Giessen, Giessen

All Listed Sponsors
collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

lead

University of Giessen

OTHER

NCT05043168 - Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination | Biotech Hunter | Biotech Hunter